Stem-Cell Transplantation in Adult Patients with Relapsed/Refractory Hodgkin Lymphoma
Although the majority of patients with Hodgkin lymphoma (HL) are cured with initial therapy, in 85–90% of early stage and 70–80% of advanced-stage disease cases, relapse remains a major problem. Autologous stem-cell transplantation (auto-HCT) after salvage chemotherapy is currently considered to be...
Main Authors: | Sonja Genadieva Stavrik, Anna Sureda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Transplantology |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-3943/2/4/38 |
Similar Items
-
Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation
by: Eva Domingo-Domènech, et al.
Published: (2020-05-01) -
Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma
by: Chen Zhang, et al.
Published: (2023-05-01) -
Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Lymphoma: Recent Advances and Outcomes
by: Taha Al-Juhaishi, et al.
Published: (2022-01-01) -
The role of transplantation in Hodgkin lymphoma
by: Michael Maranzano, et al.
Published: (2023-01-01) -
Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report
by: Federica Giannotti, et al.
Published: (2024-03-01)